Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma

Figure 5

Immune signatures with multivariate Cox regression with prognostic capabilities in HNSCC and enriched GO and KEGG. (a) Thirty-five genes with prognostic ability were screen out by univariate Cox analysis and log-rank test for TCGA HNSCC datasets (). Twenty genes with were favorable prognosis factors, while 15 genes with were adverse prognosis factors in HNSCC. (b–i) Kaplan-Meier plots of the top eight independent survival-related genes. (j–k) Kaplan-Meier curves and time-dependent ROC curves of the prediction model.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)